Position in TMO
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$93,523,413
New position
Shares Held
190,270
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.4854680191307.ToString("F0")%
Shared 0.ToString("F0")%
None 0.514531980869291.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SEB Asset Management AB holds $267,177,780 across 12 Diagnostics & Research names. TMO ranks #1 (35.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
190,270 | $93,523,413 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
228,726 | $39,006,932 | |
| 3 | DGX |
Quest Diagnostics Inc
|
139,951 | $27,427,596 | |
| 4 | DHR |
Danaher Corp /De/
|
129,944 | $24,637,382 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
36,527 | $20,524,156 | |
| 6 | NTRA |
Natera, Inc.
|
85,074 | $17,013,949 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
12,598 | $15,888,597 | |
| 8 | ILMN |
Illumina, Inc.
|
68,814 | $8,482,013 |
All Filings in TMO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93,523,413 | 190,270 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||